{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T22:39:48Z","timestamp":1793572788299,"version":"4.5.0"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,10]]},"abstract":"<jats:sec>\n            <jats:title>Purpose:<\/jats:title>\n            <jats:p>To compare the effects of half-dose photodynamic therapy (PDT) and high-density subthreshold micropulse laser on choroidal dysfunction evaluated by degree and extent of hyperfluorescence on indocyanine green angiography (ICGA) in chronic central serous chorioretinopathy.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Data from the multicenter, randomized, controlled PLACE trial were used in this study. Hyperfluorescent and hypofluorescent areas on ICGA, their association with subretinal fluid and visual function were assessed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>In total, 146 patients were included (72 in the PDT and 74 in the high-density subthreshold micropulse laser treatment arm). A significantly greater decrease in the size of hyperfluorescent areas on ICGA at first visit after treatment was seen after PDT compared with high-density subthreshold micropulse laser (mean, \u22121.41 \u00b1 2.40 mm<jats:sup>2<\/jats:sup> vs. \u22120.04 \u00b1 0.73 mm<jats:sup>2<\/jats:sup>, respectively; <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.001). A reduction in the degree of hyperfluorescence on ICGA decreased the odds of having persistent subretinal fluid on optical coherence tomography at first visit after treatment (B = 0.295; <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.019). There were no significant differences in best-corrected visual acuity and retinal sensitivity between the subgroup with novel hypofluorescence (n = 20, 28%) on ICGA at first visit post PDT, compared with the subgroup without novel hypofluorescence on ICGA after PDT.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>Choroidal abnormalities in chronic central serous chorioretinopathy can be effectively treated by ICGA-guided half-dose PDT but not with high-density subthreshold micropulse laser application.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/iae.0000000000003157","type":"journal-article","created":{"date-parts":[[2021,2,27]],"date-time":"2021-02-27T07:07:05Z","timestamp":1614409625000},"page":"2122-2131","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":16,"title":["RESPONSE OF CHOROIDAL ABNORMALITIES TO PHOTODYNAMIC THERAPY VERSUS MICROPULSE LASER IN CHRONIC CENTRAL SEROUS CHORIORETINOPATHY"],"prefix":"10.1097","volume":"41","author":[{"given":"Thomas J.","family":"van Rijssen","sequence":"first","affiliation":[{"name":"Ophthalmology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leo C.","family":"Hahn","sequence":"additional","affiliation":[{"name":"Ophthalmology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elon H.C.","family":"van Dijk","sequence":"additional","affiliation":[{"name":"Ophthalmology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roula","family":"Tsonaka","sequence":"additional","affiliation":[{"name":"Biomedical Data Sciences, Leiden University Medical Center, Leiden, the Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Scholz","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University Hospital of Cologne, Cologne, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myrte B.","family":"Breukink","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Radboud University Medical Center, Nijmegen, the Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rocio","family":"Blanco-Garavito","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Centre Hospitalier Intercommunal de Creteil University Paris Est Creteil, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric H.","family":"Souied","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Centre Hospitalier Intercommunal de Creteil University Paris Est Creteil, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan E.E.","family":"Keunen","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Radboud University Medical Center, Nijmegen, the Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert E.","family":"MacLaren","sequence":"additional","affiliation":[{"name":"Oxford Eye Hospital, John Radcliffe Hospital, Oxford University Hospitals NHS Foundation Trust, West Wing, Oxford, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Querques","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Centre Hospitalier Intercommunal de Creteil University Paris Est Creteil, Paris, France;"},{"name":"Department of Ophthalmology, IRCCS Ospedale San Raffaele, Vita-Salute University, Milan, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sascha","family":"Fauser","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University Hospital of Cologne, Cologne, Germany;"},{"name":"F. Hoffmann-La Roche, Basel, Switzerland; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan M.","family":"Downes","sequence":"additional","affiliation":[{"name":"Oxford Eye Hospital, John Radcliffe Hospital, Oxford University Hospitals NHS Foundation Trust, West Wing, Oxford, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carel B.","family":"Hoyng","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Radboud University Medical Center, Nijmegen, the Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camiel J.F.","family":"Boon","sequence":"additional","affiliation":[{"name":"Ophthalmology, and"},{"name":"Department of Ophthalmology, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250607","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.1600-0420.2007.00889.x","article-title":"Central serous chorioretinopathy","volume":"86","author":"Wang","year":"2008","journal-title":"Acta Ophthalmol"},{"key":"R2-20250607","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.preteyeres.2015.05.003","article-title":"Central serous chorioretinopathy: recent findings and new physiopathology hypothesis","volume":"48","author":"Daruich","year":"2015","journal-title":"Prog Retin Eye Res"},{"key":"R3-20250607","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/IAE.0000000000000837","article-title":"Risk factors for central serous chorioretinopathy: a systematic review and meta-analysis","volume":"36","author":"Liu","year":"2016","journal-title":"Retina"},{"key":"R4-20250607","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1097\/IAE.0000000000001966","article-title":"Familial central serous chorioretinopathy","volume":"39","author":"van Dijk","year":"2019","journal-title":"Retina"},{"key":"R5-20250607","doi-asserted-by":"crossref","first-page":"100770","DOI":"10.1016\/j.preteyeres.2019.07.003","article-title":"Central serous chorioretinopathy: towards an evidence-based treatment guideline","volume":"73","author":"van Rijssen","year":"2019","journal-title":"Prog Retin Eye Res"},{"key":"R6-20250607","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1097\/IAE.0b013e3181be0a83","article-title":"Enhanced depth imaging optical coherence tomography of the choroid in central serous chorioretinopathy","volume":"29","author":"Imamura","year":"2009","journal-title":"Retina"},{"key":"R7-20250607","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/eye.1995.63","article-title":"Indocyanine green angiographic findings in central serous chorioretinopathy","volume":"9","author":"Cardillo Piccolino","year":"1995","journal-title":"Eye (Lond)"},{"key":"R8-20250607","doi-asserted-by":"crossref","first-page":"587\/515","DOI":"10.1016\/0002-9394(67)90028-1","article-title":"Pathogenesis of disciform detachment of the neuroepithelium","volume":"63","author":"Donald","year":"1967","journal-title":"Am J Ophthalmol"},{"key":"R9-20250607","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.ophtha.2018.12.048","article-title":"Long-term visual outcomes and causes of vision loss in chronic central serous chorioretinopathy","volume":"126","author":"Mrejen","year":"2019","journal-title":"Ophthalmology"},{"key":"R10-20250607","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1016\/j.ophtha.2018.04.021","article-title":"Half-dose photodynamic therapy versus high-density subthreshold micropulse laser treatment in patients with chronic central serous chorioretinopathy: the place trial","volume":"125","author":"van Dijk","year":"2018","journal-title":"Ophthalmology"},{"key":"R11-20250607","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.ophtha.2013.11.040","article-title":"Collaborative retrospective macula society study of photodynamic therapy for chronic central serous chorioretinopathy","volume":"121","author":"Lim","year":"2014","journal-title":"Ophthalmology"},{"key":"R12-20250607","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/IAE.0b013e3182670fbe","article-title":"Photodynamic therapy for chronic central serous chorioretinopathy: a 4-year follow-up study","volume":"33","author":"Silva","year":"2013","journal-title":"Retina"},{"key":"R13-20250607","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1136\/bjo.87.12.1453","article-title":"Choroidal vascular remodelling in central serous chorioretinopathy after indocyanine green guided photodynamic therapy with verteporfin: a novel treatment at the primary disease level","volume":"87","author":"Chan","year":"2003","journal-title":"Br J Ophthalmol"},{"key":"R14-20250607","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1167\/iovs.12-11382","article-title":"The comparative histologic effects of subthreshold 532- and 810-nm diode micropulse laser on the retina","volume":"54","author":"Yu","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R15-20250607","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/IAE.0b013e3181e378f2","article-title":"Comparison of efficacy and safety between half-fluence and full-fluence photodynamic therapy for chronic central serous chorioretinopathy","volume":"31","author":"Shin","year":"2011","journal-title":"Retina"},{"key":"R16-20250607","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3109\/02713683.2014.1002047","article-title":"Multimodal imaging and choroidal volumetric changes after half-fluence pdt in central serous chorioretinopathy","volume":"41","author":"Munk","year":"2016","journal-title":"Curr Eye Res"},{"key":"R17-20250607","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1016\/j.ophtha.2010.01.023","article-title":"Subfoveal choroidal thickness after treatment of central serous chorioretinopathy","volume":"117","author":"Maruko","year":"2010","journal-title":"Ophthalmology"},{"key":"R18-20250607","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/eye.2017.293","article-title":"Visual outcomes and anatomic changes after sub-threshold micropulse yellow laser (577-nm) treatment for chronic central serous chorioretinopathy: long-term follow-up","volume":"32","author":"Arsan","year":"2018","journal-title":"Eye (Lond)"},{"key":"R19-20250607","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s10384-008-0613-z","article-title":"Severe choroidal ischemia following photodynamic therapy for pigment epithelial detachment and chronic central serous chorioretinopathy","volume":"53","author":"Lee","year":"2009","journal-title":"Jpn J Ophthalmol"},{"key":"R20-20250607","first-page":"CS75","article-title":"Severe decrease in visual acuity with choroidal hypoperfusion after photodynamic therapy","volume":"17","author":"Figurska","year":"2011","journal-title":"Med Sci Monit"},{"key":"R21-20250607","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/IAE.0000000000001138","article-title":"Comparison of photodynamic therapy using half-dose of verteporfin or half-fluence of laser light for the treatment of chronic central serous chorioretinopathy","volume":"37","author":"Cheng","year":"2017","journal-title":"Retina"},{"key":"R22-20250607","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1186\/s13063-015-0939-z","article-title":"Comparing half-dose photodynamic therapy with high-density subthreshold micropulse laser treatment in patients with chronic central serous chorioretinopathy (the place trial): study protocol for a randomized controlled trial","volume":"16","author":"Breukink","year":"2015","journal-title":"Trials"},{"key":"R23-20250607","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ajo.2019.03.025","article-title":"Focal and diffuse chronic central serous chorioretinopathy treated with half-dose photodynamic therapy or subthreshold micropulse laser: place trial report No. 3","volume":"205","author":"van Rijssen","year":"2019","journal-title":"Am J Ophthalmol"},{"key":"R24-20250607","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1007\/s00417-019-04333-y","article-title":"Patient characteristics of untreated chronic central serous chorioretinopathy patients with focal versus diffuse leakage","volume":"257","author":"van Rijssen","year":"2019","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R25-20250607","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.ajo.2009.10.011","article-title":"Association between the efficacy of photodynamic therapy and indocyanine green angiography findings for central serous chorioretinopathy","volume":"149","author":"Inoue","year":"2010","journal-title":"Am J Ophthalmol"},{"key":"R26-20250607","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1097\/00006982-199911000-00005","article-title":"Persistent and bilateral choroidal vascular abnormalities in central serous chorioretinopathy","volume":"19","author":"Iida","year":"1999","journal-title":"Retina"},{"key":"R27-20250607","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.pdpdt.2014.07.005","article-title":"Evaluation of the effects of photodynamic therapy on chronic central serous chorioretinopathy based on the mean choroidal thickness and the lumen area of abnormal choroidal vessels","volume":"11","author":"Hua","year":"2014","journal-title":"Photodiagnosis Photodyn Ther"},{"key":"R28-20250607","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.ajo.2015.01.006","article-title":"Change of regional choroid thickness after reduced-fluence photodynamic therapy for chronic central serous chorioretinopathy","volume":"159","author":"Manabe","year":"2015","journal-title":"Am J Ophthalmol"},{"key":"R29-20250607","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.2147\/OPTH.S174573","article-title":"Clinical spectrum of severe chronic central serous chorioretinopathy and outcome of photodynamic therapy","volume":"12","author":"Mohabati","year":"2018","journal-title":"Clin Ophthalmol"},{"key":"R30-20250607","doi-asserted-by":"crossref","first-page":"P80","DOI":"10.1016\/j.ajo.2020.04.007","article-title":"Cross-over to photodynamic therapy or micropulse laser after failure of primary treatment of chronic central serous chorioretinopathy","volume":"216","author":"van Rijssen","year":"2020","journal-title":"Am J Ophthalmol"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000003157","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T18:02:09Z","timestamp":1749319329000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000003157"}},"subtitle":["Place Trial Report No. 4"],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":30,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0000000000003157","relation":{},"ISSN":["0275-004X"],"issn-type":[{"value":"0275-004X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]}}}